Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pomalidomide
Drug ID BADD_D01798
Description Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Indications and Usage Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Marketing Status approved
ATC Code L04AX06
DrugBank ID DB08910
KEGG ID D08976
MeSH ID C467566
PubChem ID 134780
TTD Drug ID D0A3ZU
NDC Product Code 65015-893; 17337-0068; 63069-404; 68554-0092; 70225-1106; 59572-501; 59572-502; 55111-989; 68554-0091; 82245-0108; 63069-402; 42973-232; 54893-0038; 59572-503; 59572-504; 63069-403
UNII D2UX06XLB5
Synonyms pomalidomide | CC-4047 | CC 4047 | CC4047 | Imnovid | Pomalyst | actimid
Chemical Information
Molecular Formula C13H11N3O4
CAS Registry Number 19171-19-8
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ear swelling04.03.01.0140.001881%Not Available
Embolism arterial24.01.01.014--
Embolism venous24.01.01.003--Not Available
Epistaxis24.07.01.005; 22.04.03.001--
Essential tremor17.01.06.0040.000940%Not Available
Eye discharge06.04.05.0010.001302%Not Available
Eye disorder06.08.03.0010.009524%Not Available
Eye swelling06.08.03.0030.013985%Not Available
Faeces hard07.01.03.0030.002291%Not Available
Failure to thrive19.07.05.001; 18.04.01.003; 14.03.02.0080.001326%Not Available
Fall12.01.08.002--
Fatigue08.01.01.0020.556343%
Febrile neutropenia08.05.02.004; 01.02.03.0020.009741%
Feeling abnormal08.01.09.0140.061484%Not Available
Feeling jittery08.01.09.0160.010199%Not Available
Femur fracture15.08.03.003; 12.04.01.003--Not Available
Flatulence07.01.04.0020.018879%
Fluid retention20.01.02.003; 14.05.06.0020.025751%Not Available
Food allergy10.01.01.0120.001640%Not Available
Food poisoning12.03.01.024; 11.07.02.001; 07.11.01.0070.003665%Not Available
Gallbladder disorder09.03.02.0010.004605%Not Available
Gastric dilatation07.02.02.0020.000530%Not Available
Gastrointestinal disorder07.11.01.001--Not Available
Gingival disorder07.09.13.0040.001543%Not Available
Gingival pain07.09.13.0100.003810%
Gingival swelling07.09.13.0130.002700%Not Available
Glossodynia07.14.02.0010.004051%Not Available
Gout14.09.01.001; 15.01.06.0010.009211%Not Available
Graft versus host disease12.02.09.001; 10.02.01.0270.000844%Not Available
Haemoglobin decreased13.01.05.003--Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 16 Pages